Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia

机译：为亚洲过敏性鼻炎和荨麻疹选择最佳的第二代抗组胺药

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundAllergic diseases are on the rise in many parts of the world, including the Asia–Pacific (APAC) region. Second-generation antihistamines are the first-line treatment option in the management of allergic rhinitis and urticaria. International guidelines describe the management of these conditions; however, clinicians perceive the additional need to tailor treatment according to patient profiles. This study serves as a consensus of experts from several countries in APAC (Hong Kong, Malaysia, the Philippines, Singapore, Thailand, Vietnam), which aims to describe the unmet needs, practical considerations, challenges, and key decision factors when determining optimal second-generation antihistamines for patients with allergic rhinitis and/or urticaria.

机译：背景技术过敏性疾病在世界许多地区（包括亚太地区）都在增加。第二代抗组胺药是过敏性鼻炎和荨麻疹的一线治疗选择。国际准则描述了这些情况的管理；然而，临床医生认为还需要根据患者情况调整治疗方案。这项研究是亚太地区（香港，马来西亚，菲律宾，新加坡，泰国，越南）多个国家/地区的专家的共识，旨在描述确定最佳秒数时未满足的需求，实际考虑，挑战和关键决策因素代抗过敏性鼻炎和/或荨麻疹的新一代抗组胺药。

著录项

期刊名称 Clinical and Molecular Allergy : CMA
作者
Marysia Tiongco Recto; Ma. Teresita Gabriel; Kanokvalai Kulthanan; Pongsakorn Tantilipikorn; Derrick Chen-Wee Aw; Tak Hong Lee; Ch’ng Chin Chwen; Somasundran Mutusamy; Nguyen Trong Hao; Vo Thanh Quang; Giorgio Walter Canonica;
展开▼
作者单位

展开▼
年(卷),期 2017(15),-1
年度 2017
页码 19
总页数 12
原文格式 PDF
正文语种
中图分类分子生物学;
关键词
Allergic rhinitis Antihistamines Bilastine Treatment algorithm Urticaria;

机译：过敏性鼻炎;抗组胺药;双向弹性蛋白;治疗方案;荨麻疹;

相似文献

外文文献
中文文献
专利

1. Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia [J] . Marysia Tiongco Recto, Ma. Teresita Gabriel, Kanokvalai Kulthanan, Clinical and Molecular Allergy . 2017,第1期

机译：为亚洲过敏性鼻炎和荨麻疹选择最佳的第二代抗组胺药
2. CSACI position statement: Newer generation H 1 -antihistamines are safer than first-generation H 1 -antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria [J] . Michael N. Fein, David A. Fischer, Andrew W. O’Keefe, Allergy, Asthma & Clinical Immunology . 2019,第1期

机译：CSACI立场声明：新一代H 1-抗组胺药比第一代H 1-抗组胺药更安全，应成为治疗变应性鼻炎和荨麻疹的一线抗组胺药
3. Antihistamines in the pediatric population: achieving optimal outcomes when treating seasonal allergic rhinitis and chronic urticaria. [J] . Schad CA, Skoner DP Allergy and asthma proceedings . 2008,第1期

机译：儿科人群中的抗组胺药：治疗季节性变应性鼻炎和慢性荨麻疹时可达到最佳效果。
4. A BIOMIMETIC APPROACH OF RECOGNITIVE CONTACT LENSES FOR TAILORED LOADING AND RELEASE OF ANTIHISTAMINES TO TREAT ALLERGIC RHINOCONJUNCTIVITIS [C] . S. Venkatesh, S.P. Sizemore, J.B. Zhang, Society for Biomaterials Transaction Annual Meeting vol.29 pt.1 . 2006

机译：识别性接触镜片的生物组学方法，可用于抗过敏药的尾部加载和释放，以治疗过敏性鼻结膜炎
5. Narrative analysis on parent-child relational closeness, acculturation, and racial preference in mate selection among second-generation Asian Americans [D] . Sklar, Quyen T. 2016

机译：第二代亚裔美国人在伴侣选择中父子关系的叙事分析，文化和种族偏好
6. CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria [O] . Michael N. Fein, David A. Fischer, Andrew W. O’Keefe, 2019

机译：CSACI立场声明：新一代H1抗组胺药比第一代H1抗组胺药更安全应成为治疗变应性鼻炎和荨麻疹的一线抗组胺药
7. The clinical evidence of second-generation H1-antihistamines in the treatment of allergic rhinitis and urticaria in children over 2 years with a special focus on rupatadine [O] . Antonio Nieto, María Nieto, Ángel Mazón 2020

机译：2年儿童过敏性鼻炎和荨麻疹治疗过敏性鼻炎和荨麻疹的临床证据，特别关注Rupatain

Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia

摘要

著录项

相似文献

相关主题

期刊订阅